CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics Holdings Inc. (Nasdaq: CDIO), an artificial intelligence-powered precision cardiovascular medicine company, today announced that the Japan Patent Office ...

CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics Holdings, Inc (Nasdaq: CDIO), a pioneer of artificial intelligence-driven precision cardiovascular medicine tests, today announced its AI-driven molecular ...

Cardiovascular disease is the leading cause of death worldwide. The primary objective of therapies is to reduce the incidence of major adverse cardiovascular events (MACE). The leading class of drugs ...

New solutions for improving and managing cardiovascular health are urgently needed, but effective and worthwhile solutions often fail to make it to patients because all critical stakeholders are not ...

Johnson & Johnson sealed its biggest deal in six years by acquiring cardiovascular med tech company Abiomed for $16.6 billion, the company announced Tuesday. Abiomed, which develops heart pumps, will ...

Please provide your email address to receive an email when new articles are posted on . Geographic health disparities are multifactorial and present barriers to optimal cardio-obstetrics care.

Modern cardiovascular care involves human acumen, complex data and collaborative intelligence between the two. Payment models are based on well-defined tests and procedures and are baffled by the ...

Jun 10, 2025, 8:35 AM ETCardio Diagnostics Holdings, Inc. (CDIO) “We are proud to support this important innovation from the University of Iowa ecosystem,” said Marie Kerbeshian, Ph.D., Executive ...